Skip to main content

Table 2 The baseline lipid profiles for EL 2037 T/C and 2237 G/A genotypes in CAD patients

From: Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin

SNPs

N

TCa (mmol/l)

TG (mmol/l)

HDL-C (mmol/l)

LDL-C (mmol/l)

2037 T/C

 TT

68

4.74 ± 1.00

1.98 ± 1.17

1.08 ± 0.25

2.90 ± 0.87

 TC

47

4.47 ± 0.88

2.08 ± 1.27

1.09 ± 0.36

2.64 ± 0.74

 CC

6

3.92 ± 0.85

1.91 ± 0.57

0.82 ± 0.18

2.32 ± 0.78

 TC + CC

53

4.41 ± 0.89

2.06 ± 1.21

1.06 ± 0.36

2.60 ± 0.74*

2237 G/A

 GG

46

4.63 ± 1.08

1.81 ± 0.95

1.04 ± 0.28

2.87 ± 0.93

 GA

60

4.60 ± 0.85

2.21 ± 1.33

1.11 ± 0.33

2.69 ± 0.75

 AA

15

4.45 ± 1.05

1.85 ± 1.16

1.03 ± 0.24

2.81 ± 0.80

 GA + AA

75

4.57 ± 0.89

2.14 ± 1.30

1.09 ± 0.32

2.71 ± 0.76

  1. SNPs single nucleotide polymorphisms, N number, TC a total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol
  2. * P < 0.05 compared with TT group